Skip Navigation



NDT Advance Access published online on March 24, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh711
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/6/1093    most recent
gfh711v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kanková, K.
Right arrow Articles by Znojil, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanková, K.
Right arrow Articles by Znojil, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received July 13, 2004
Accepted January 5, 2005

Original Articles

Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus

Katerina Kanková 1*, Andrea Stejskalová 1, Miluse Hertlová 2, and Vladimír Znojil 1

1 Department of Pathophysiology, Faculty of Medicine, Masaryk University Brno, Czech Republic
2 Third Department of Internal Medicine, University Hospital Brno-Bohunice, Czech Republic

* To whom correspondence should be addressed.
Katerina Kanková, E-mail: kankov{at}med.muni.cz



  Abstract

Background. Diabetic nephropathy (DN) represents a devastating complication of diabetes. Family clustering, heterogeneity in the onset and progression and results of segregation studies indicate that susceptibility to DN is a complex trait.

Methods. Common single nucleotide polymorphisms in the RAGE (receptor of advanced glycation end-products) gene (-429T/C, -374T/A, G82S, 1704G/T, 2184A/G and 2245G/A) were studied in the association study comprising 605 Caucasian subjects by means of haplotype analysis in order to identify an eventual haplotype marker for DN in type 2 diabetes. Haplotypes were constructed computationally; frequencies were compared among groups of subjects with type 2 diabetes (DM) and DN, diabetics without DN and non-diabetics. Survival analysis was carried out to ascertain whether certain RAGE haplotypes influence onset of DN in type 2 diabetics.

Results. Significant differences in haplotype frequencies among DM + DN vs DM non-DN and non-DM groups were found (P = 0.0007 and 0.0013, respectively; permutation test). Frequency of the RAGE2 haplotype containing minor alleles in positions -429 and 2184 (CTGGGG) in the DN group was significantly higher than in the two control groups (21.7% vs 12.8% and 13.8%, both Pcorr<0.003; two-tail Fisher exact test); odds ratios 1.65 [95% confidence interval (CI): 1.08-2.50; P = 0.020] and 1.79 (95% CI: 1.22-2.62; P = 0.003), respectively. In survival analysis, duration of diabetes until the onset of DN (e.g. appearance of persistent proteinuria) was significantly different among RAGE2 diplotype groups (P<0.05); median DN-free interval was 9.6 years in RAGE2 +/+ homozygotes, 15.2 years in +/- heterozygotes and 17.0 years in the -/- combination.

Conclusions. The RAGE2 haplotype is associated with DN in type 2 diabetics and with earlier DN onset and, thus, can be regarded a marker for DN.

Keywords: advanced glycation end-products; complications; diabetic nephropathy; haplotype analysis; polymorphism; RAGE.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. Kalousova, M. Jachymova, O. Mestek, M. Hodkova, M. Kazderova, V. Tesar, and T. Zima
Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 2020 - 2026.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.